- Full text PDF available (0)
- This year (1)
- Last five years (1)
BACKGROUND This multicentre, randomized study was designed to assess the clinical efficacy, safety and tolerability of three novel 7-day triple therapies containing ranitidine bismuth citrate (RBC) and two antibiotics. METHODS We studied patients with non-ulcer dyspepsia and gastritis who were randomly assigned to one of three treatment regimens given for… (More)
We reported a case of lipoid proteinosis with severe respiratory symptomatology. Diagnosis has been made out of clinical and histological data by laryngeal biopsy. Immunohistochemistry confirms the altered composition of extracellular matrix.
BACKGROUND No clinical study has been performed to-date to evaluate the efficacy of the dual therapy of ranitidine bismuth citrate (RBC) plus clarithromycin (C) 500 mg b.d. given for 7 days for the eradication of H. pylori. AIM To assess the eradication rates achieved by treatment with RBC 400 mg b.d. for 28 days combined with clarithromycin 500 mg b.d.… (More)